Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In this chapter we review research on the diagnosis, course, etiology, and pharmacological and psychosocial treatment of bipolar disorder (BD). BD is a highly recurrent and severe illness, with high rates of suicidality and functional impairment. The disorder is heritable and appears to share susceptibility genes with schizophrenia. It is characterized by dysregulation in the dopamine and serotonin systems and by pathology in the brain systems involved in regulating emotion. Psychosocial stressors, notably life events and familial expressed emotion, significantly influence the course of the illness in the context of these vulnerabilities. Findings of randomized clinical trials indicate that psychosocial interventions enhance long-term outcomes when added to pharmacotherapy. Much remains to be clarified about the interactive contributions of genetic, neurobiological, and psychosocial factors to the course of the disorder, and the moderators and mediators of treatment effects.

Original publication

DOI

10.1146/annurev.clinpsy.2.022305.095332

Type

Journal article

Journal

Annu Rev Clin Psychol

Publication Date

2006

Volume

2

Pages

199 - 235

Keywords

Anticonvulsants, Antidepressive Agents, Antimanic Agents, Antipsychotic Agents, Bipolar Disorder, Comorbidity, Cost of Illness, Genetic Predisposition to Disease, Humans, Lithium Compounds, Neurotransmitter Agents, Psychotherapy, Randomized Controlled Trials as Topic, Risk Factors, Suicide, Treatment Outcome